58 related articles for article (PubMed ID: 37160628)
1. A review on trends in development and translation of omics signatures in cancer.
Ma W; Tang W; Kwok JSL; Tong AHY; Lo CWS; Chu ATW; Chung BHY;
Comput Struct Biotechnol J; 2024 Dec; 23():954-971. PubMed ID: 38385061
[TBL] [Abstract][Full Text] [Related]
2. Systematic analysis of transcriptome signature for improving outcomes in lung adenocarcinoma.
Ge X; Xu H; Weng S; Zhang Y; Liu L; Wang L; Xing Z; Ba Y; Liu S; Li L; Wang Y; Han X
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8951-8968. PubMed ID: 37160628
[TBL] [Abstract][Full Text] [Related]
3. Identification of disulfidptosis-related subgroups and prognostic signatures in lung adenocarcinoma using machine learning and experimental validation.
Wang Y; Xu Y; Liu C; Yuan C; Zhang Y
Front Immunol; 2023; 14():1233260. PubMed ID: 37799714
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of an immune-related prognostic signature in lung adenocarcinoma.
Sun S; Guo W; Wang Z; Wang X; Zhang G; Zhang H; Li R; Gao Y; Qiu B; Tan F; Gao Y; Xue Q; Gao S; He J
Cancer Med; 2020 Aug; 9(16):5960-5975. PubMed ID: 32592319
[TBL] [Abstract][Full Text] [Related]
5. Clinical Significance and Immunologic Landscape of a Five-IL(R)-Based Signature in Lung Adenocarcinoma.
Fan T; Pan S; Yang S; Hao B; Zhang L; Li D; Geng Q
Front Immunol; 2021; 12():693062. PubMed ID: 34497605
[TBL] [Abstract][Full Text] [Related]
6. Identification of immune-related gene signature predicting survival in the tumor microenvironment of lung adenocarcinoma.
Zhao M; Li M; Chen Z; Bian Y; Zheng Y; Hu Z; Liang J; Huang Y; Yin J; Zhan C; Feng M; Wang Q
Immunogenetics; 2020 Dec; 72(9-10):455-465. PubMed ID: 33188484
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
8. Risk score = LncRNAs associated with doxorubicin metabolism can be used as molecular markers for immune microenvironment and immunotherapy in non-small cell lung cancer.
Lin Q; Zhang M; Kong Y; Huang Z; Zou Z; Xiong Z; Xie X; Cao Z; Situ W; Dong J; Li S; Zhu X; Huang Y
Heliyon; 2023 Mar; 9(3):e13811. PubMed ID: 36879965
[TBL] [Abstract][Full Text] [Related]
9. Predictive modeling reveals that higher-order cooperativity drives transcriptional repression in a synthetic developmental enhancer.
Kim YJ; Rhee K; Liu J; Jeammet S; Turner MA; Small SJ; Garcia HG
Elife; 2022 Dec; 11():. PubMed ID: 36503705
[TBL] [Abstract][Full Text] [Related]
10. Multi-omics landscape and clinical significance of a
Wang L; Liu Z; Zhu R; Liang R; Wang W; Li J; Zhang Y; Guo C; Han X; Sun Y
Comput Struct Biotechnol J; 2022; 20():1154-1167. PubMed ID: 35317237
[No Abstract] [Full Text] [Related]
11. An Integrated Fibrosis Signature for Predicting Survival and Immunotherapy Efficacy of Patients With Hepatocellular Carcinoma.
Liu L; Liu Z; Meng L; Li L; Gao J; Yu S; Hu B; Yang H; Guo W; Zhang S
Front Mol Biosci; 2021; 8():766609. PubMed ID: 34970594
[No Abstract] [Full Text] [Related]
12. Diagnostic, Predictive, and Prognostic Biomarkers in Non-Small Cell Lung Cancer (NSCLC) Management.
Šutić M; Vukić A; Baranašić J; Försti A; Džubur F; Samaržija M; Jakopović M; Brčić L; Knežević J
J Pers Med; 2021 Oct; 11(11):. PubMed ID: 34834454
[TBL] [Abstract][Full Text] [Related]
13. Gene Expression Profiling as a Potential Tool for Precision Oncology in Non-Small Cell Lung Cancer.
Hijazo-Pechero S; Alay A; Marín R; Vilariño N; Muñoz-Pinedo C; Villanueva A; Santamaría D; Nadal E; Solé X
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638221
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
